Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177 lu-dotatate in the phase III netter-1 trial
on behalf of the NETTER-1 study group
Research output: Contribution to journal › Article › peer-review
284Scopus
citations
Fingerprint
Dive into the research topics of 'Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177 lu-dotatate in the phase III netter-1 trial'. Together they form a unique fingerprint.